Skerritt JH, Johnston GA, Enhancement of GABA binding by benzodiazepines and related anxiolytics, in Eur. J. Pharmacol., vol. 89, n. 3-4, Maggio 1983, pp. 193–8, PMID6135616.
Oelschläger H, Chemical and pharmacologic aspects of benzodiazepines, in Schweiz. Rundsch. Med. Prax., vol. 78, n. 27-28, Luglio 1989, pp. 766–72, PMID2570451.
Christensen P, Lolk A, Gram LF, Kragh-Sørensen P, Benzodiazepine-induced sedation and cortisol suppression. A placebo-controlled comparison of oxazepam and nitrazepam in healthy male volunteers, in Psychopharmacology (Berl.), vol. 106, n. 4, 1992, pp. 511–6, PMID1349754.
Greenblatt DJ, Clinical pharmacokinetics of oxazepam and lorazepam, in Clin Pharmacokinet, vol. 6, n. 2, 1981, pp. 89–105, PMID6111408.
Olive G, Dreux C, [Pharmacologic bases of use of benzodiazepines in peréinatal medicine], in Archives Françaises De Pédiatrie, vol. 34, n. 1, Gennaio 1977, pp. 74–89, PMID851373.
Gaudreault P, Guay J, Thivierge RL, Verdy I, Benzodiazepine poisoning. Clinical and pharmacological considerations and treatment, in Drug Safety, vol. 6, n. 4, 1991, pp. 247–65, PMID1888441.
Perry HE, Shannon MW, Diagnosis and management of opioid- and benzodiazepine-induced comatose overdose in children, in Current Opinion in Pediatrics, vol. 8, n. 3, Giugno 1996, pp. 243–7, PMID8814402.